Baylor University Medical Center, Texas Oncology Introduce Car-T Therapy

Baylor University Medical Center and Texas Oncology are the first in North Texas to offer one of the two FDA-approved CAR-T cell therapies. The specific treatment, known as Yescarta, is geared toward diffuse large B-cell lymphoma. CAR-T (Chimeric Antigen Receptor T cell therapy) is a cancer treatment in which a patient’s immune cells are removed from the body, genetically re-engineered, and then put back into the body so that they can attack the cancer. At BUMC, it will be used on adult patients who have not responded to other treatments or who have relapsed after two other kinds of treatment,… Full Story